Collagen Solutions PLC Notice of Results (1691R)
June 13 2018 - 2:01AM
UK Regulatory
TIDMCOS
RNS Number : 1691R
Collagen Solutions PLC
13 June 2018
13 June 2018
Collagen Solutions plc
("Collagen Solutions" or the "Company")
Notice of results for the year ended 31 March 2018
Analyst and investor briefing
Collagen Solutions Plc (AIM: COS), the developer and
manufacturer of biomaterials and regenerative medicines for the
enhancement and extension of human life, announces that it will
issue its audited full year results for the year ended 31 March
2018 on Tuesday, 10 July 2018.
Analyst briefing
An analyst briefing will take place at the offices of Walbrook
PR, 4 Lombard Street, London EC3V 9HD at 9.30am on Tuesday, 10 July
2018.
Investor evening
Collagen Solutions will also be hosting an afternoon
presentation for investors on Tuesday 10 July 2018, where Jamal
Rushdy, CEO of the Company, will summarise the full year results
and:
-- provide insight into the underlying business trends;
-- an overview of the ongoing positioning of the Company; and
-- outline the key milestones expected over the next period.
Hilary Spence, CFO, will present key financial highlights,
outlook and insight from her first few months with Collagen
Solutions.
This investor event will take place at the Copper Bar, upstairs
at Balls Brothers, 6 Adams Court, Old Broad St, London, EC2N 1DX at
4.30pm for a 4.45pm start. This will be followed by drinks and
canapes, and a chance to network. A video of the presentation will
be available on the Company's website shortly afterwards:
http://ir.collagensolutions.com/content/investors/presentations.asp.
If you would like to register to attend the analyst or investor
briefing or require further information, please contact Walbrook PR
on 020 7933 8780 or email collagen@walbrookpr.com.
Collagen Solutions Plc
Jamal Rushdy, CEO Via Walbrook
Hilary Spence, CFO
Lisa Baderoon, Investor Mob: 07721 413 496 or lisa.baderoon@collagensolutions.com
Relations
Cenkos Securities Plc (Nominated
Adviser and Broker)
Steve Cox (Corporate Finance) Tel: 0207 397 8900
Stephen Keys
Walbrook PR Ltd Tel: 020 7933 8780 or collagen@walbrookpr.com
Anna Dunphy Mob: 07876 741 001
Helen Cresswell Mob: 07841 917 679
About Collagen Solutions:
Collagen Solutions Plc is a global supplier, developer, and
manufacturer of medical grade collagen, tissues, and related
medical devices and components for use in regenerative medicine,
medical devices and in-vitro diagnostics and research. The Company
is also expanding its range of biomaterials-based finished medical
devices based on its internal and acquired intellectual property
for commercialisation with partners via licensing and distribution
arrangements, including ChondroMimetic(R). The Company's products
are used in a wide variety of applications including orthopaedics,
cardiovascular, dental, plastic surgery, wound healing, neurology
and urology.
For more information go to: www.collagensolutions.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
NORSFUFIEFASEEM
(END) Dow Jones Newswires
June 13, 2018 02:01 ET (06:01 GMT)
Collagen Solutions (LSE:COS)
Historical Stock Chart
From Apr 2024 to May 2024
Collagen Solutions (LSE:COS)
Historical Stock Chart
From May 2023 to May 2024